Chronic Coronary Syndromes Nowadays

taller de imágenes y fisiología intracoronaria

Multiple drugs and treatment strategies have emerged in recent years to change significantly the prognosis of patients who suffer from stable chronic angina or, in terms of the latest guidelines, “chronic coronary syndromes.” This semantic change may seem of little importance, but it is intended to remind us that these are not stable patients, but patients whose progress presents stable phases and acute phases.

This study analyzed data from 32,703 patients (from 45 countries) with chronic coronary syndromes enrolled in the CLARIFY registry from November 2009 to June 2010, with a 5-year follow-up.

The primary endpoint, cardiovascular death or non-fatal infarction, was 8% for the overall population (male 8.1%; female 7.6%).


Read also: Down with the Myth of Polymer-Free Stents in High Bleeding Risk.


The most important independent predictors of risk were prior hospitalization for heart failure, current smoking, living in Central/South America, prior infarction, prior stroke, diabetes, angina symptoms, and peripheral vascular disease.

There was a strong interaction in patients who had a history of prior infarction and who experienced angina symptoms, compared with patients with a history of infarction who were asymptomatic (11.8% vs. 8.2%, p < 0.001).

Among patients who had never experienced an infarction, the rate of events was similar for those with and without angina (6.3% vs. 6.4%, p > 0.99).


Read also: Is There a “Safe” Dose for Meat Consumption?


The rate of drug prescription based on evidence for secondary prevention was very high.

Conclusion

This registry describes the whole spectrum of patients with stable coronary syndromes and shows that, despite adequate secondary prevention, patients with both angina and prior infarction have high rates of events. This high-risk subgroup is easily identifiable and warrants intensive treatment.

2020-02-27-ehz660abierto

Original Title: Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.

Reference: Emmanuel Sorbets et al. European Heart Journal (2020) 41, 347–355.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...